i invested in MSB and just became aware of CYP over the weekend. I think CYP has great technology that addresses FDA concerns, however I am struggling to understand how advance is CYP manufacturing process comparing with Lonza. My understanding is that CYP is more vertical, because MSB has to get Lonza to do the manufacturing? i tried to read Lonza's paper published in mid 2010s re producing FDA compliant stem cells but not smart enough to understand that…
Ann: Cynata Investor Presentation, page-57
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
27.0¢ |
Change
-0.025(8.47%) |
Mkt cap ! $48.50M | |||
| Open | High | Low | Value | Volume |
| 29.5¢ | 29.5¢ | 27.0¢ | $3.553K | 12.06K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 44862 | 27.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 2500 | 1 |
View Market Depth
| Last trade - 16.10pm 02/07/2024 (20 minute delay) ? |
| CYP (ASX) Chart |